Effectiveness of Conservative Interventions in the Treatment of Trigger Finger

Last updated: April 26, 2024
Sponsor: Hacettepe University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Extracorporeal Shock Wave Therapy+ Trigger Finger Splint

Trigger Finger Splint

Experimental: Extracorporeal Shock Wave Therapy

Clinical Study ID

NCT06296017
AEŞH- EK1- 2023-115
  • Ages 18-65
  • All Genders

Study Summary

There is no study in the literature comparing the effectiveness of ESWT and splint therapy, which are the most commonly used approaches in the treatment of Trigger Finger (TF). The aim in this study is to investigate the effectiveness of ESWT and splint therapy used in the treatment of TF.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Volunteering
  • Being between the ages of 18-65
  • Being diagnosed with stage 1 or stage 2 (according to the Froimson classification)trigger finger
  • Having the language and cognitive skills to answer the questionnaires used in theevaluation

Exclusion

Exclusion Criteria:

  • Being pregnant
  • Having an inflammatory disorder
  • Having had surgery on the hand/wrist
  • Having a neurological disease
  • NSAIDs, painkillers, etc. being on medication
  • De Quervain's tenosynovitis, carpal tunnel syndrome

Study Design

Total Participants: 54
Treatment Group(s): 3
Primary Treatment: Extracorporeal Shock Wave Therapy+ Trigger Finger Splint
Phase:
Study Start date:
October 02, 2023
Estimated Completion Date:
December 31, 2024

Study Description

Volunteer patients who were clinically diagnosed with trigger finger by consulting a doctor at Etlik City Hospital, Hand Surgery Clinic will be included in the randomized controlled prospective study. Patients will be randomly divided into three groups using the 'Random Sequence Generator tab' on Random.org, a randomization website, and different treatment programs will be applied. ESWT application to a group; splint treatment with ESWT to the second group; The third group will receive only splint treatment. ESWT application will be performed on A1 puley at 15 Hz, 1000 shock wave impuls and 2.0 bar level, for a total of 5 sessions, one week apart. In addition to ESWT with the same parameters, a trigger finger splint that immobilizes the MCP joint will be recommended to the ESWT and splint treatment group. The patient will be asked to use this splint throughout the day for 8 weeks. The Splint Group will be offered the same trigger finger splint and will be asked to use it throughout the day for 8 weeks. Evaluation and measurements will be repeated for all three groups before treatment, immediately after treatment (8th week) and 4 weeks after the end of treatment (12th week). The number of individuals to participate in the study was calculated as 54 in total, with 18 people in each group (ESWT Group, ESWT+ Splint Group and Splint Group), according to the power and sample size analysis based on 80% power and 5% Type 1 error rate. Power analysis was performed based on pain intensity as the clinical endpoint.

Connect with a study center

  • Feray Karademir

    Ankara, 06100
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.